Detalhe da pesquisa
1.
NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport.
Neurobiol Dis
; 56: 79-94, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23631872
2.
Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein.
Pharmacol Res Perspect
; 2(5): e00065, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25505609
3.
Tau and caspase 3 as targets for neuroprotection.
Int J Alzheimers Dis
; 2012: 493670, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22693678
4.
D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy.
J Mol Neurosci
; 48(3): 597-602, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22956189